When we start looking at SleepCheck as an assistance to diagnosis the story becomes very different. It's no longer best in class - it's worst in class. There's the matter of what needs to be measured to unlock Medicare reimbursements, and also the matter of what it needs to measure for accurate differential diagnosis. The reality is sleep studies do far more than just indicate OSA. The leading sleep body AASM classifies around 90 sleep disorders, and these cannot be accurately diagnosed with a microphone alone.
- Forums
- ASX - By Stock
- RAP
- Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-145
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online